首页> 美国卫生研究院文献>Haematologica >Rescue factor VIII replacement to secure hemostasis in a patient with hemophilia A and inhibitors on emicizumab prophylaxis undergoing hip replacement

【2h】

Rescue factor VIII replacement to secure hemostasis in a patient with hemophilia A and inhibitors on emicizumab prophylaxis undergoing hip replacement

机译：抢救因子VIII置换以确保A血友病患者和接受艾米单抗预防的抑制剂行髋置换术时的止血效果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Haematologica
作者
Elena Santagostino; Maria Elisa Mancuso; Cristina Novembrino; Luigi Piero Solimeno; Armando Tripodi; Flora Peyvandi;
展开▼
作者单位

展开▼
年(卷),期 2019(104),8
年度 2019
页码 e380–e382
总页数 3
原文格式 PDF
正文语种
中图分类血液学检验;
关键词
入库时间 2022-08-17 12:08:52

相似文献

外文文献
中文文献
专利

1. Efficacy of emicizumab prophylaxis versus factor VIII prophylaxis for treatment of hemophilia A without inhibitors: network meta-analysis and sub-group analyses of the intra-patient comparison of the HAVEN 3 trial [J] . Reyes Adriana, Revir Cedric, Niggli Markus, Current medical research and opinion . 2019,第12期

机译：Emicizumab预防对因子VIII预防治疗血友病A没有抑制剂的疗效：网络元分析和患者内避风中的患者内部比较的分析
2. The perioperative von willebrand factor activity and factor VIII levels among alcohol use disorder patients undergoing total knee or hip replacement [J] . SchoenfeldH., PerkaC., ZiemerS., Substance use & misuse . 2010,第7a8期

机译：接受全膝或髋关节置换术的酒精滥用障碍患者围手术期的von willebrand因子活性和VIII因子水平
3. Oral direct factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement a systematic review and meta-analysis [J] . NeumannI., RadaG., ClaroJ.C., Annals of Internal Medicine . 2012,第10期

机译：口服直接因子Xa抑制剂与低分子量肝素联合预防全髋关节或膝关节置换患者的静脉血栓栓塞的系统评价和荟萃分析
4. Inactiwatlon of Animal Factor VIII by human Factor VIII Inhibitors: Inwestigation of Plasma from Patients with Inhibitors in congenital Hemophilia I and from Patients with acquired Hemophilia A [C] . V. Aumann, G. Lutze (Jr.), G. Lutze (Sen.), Hemophilie-Symposion . 2003

机译：人为因子VIII抑制剂的动物因子VIII的乙酰丁酮：先天性血友病药中抑制剂患者的血浆中的预防
5. Satisfaction, Adherence, and Recombinant Factor VIII Choice of Patients with Moderate to Severe Hemophilia A [D] . Strickland, Kimberly. 2020

机译：满意度，依从性和重组因素VIII患者中度至重度血友病的患者
6. Factor VIII replacement prophylaxis in patients with hemophilia A transitioning to adults: a systematic literature review [O] . Jing Sun, Xuan Zhou, Nan Hu 2021

机译：因子VIII血栓转移到成人患者的替代预防：系统文献综述
7. Reply: RE: Reyes A, Révil C, Niggli M, et al. Efficacy of emicizumab prophylaxis versus factor VIII prophylaxis for treatment of hemophilia A without inhibitors: network meta-analysis and sub-group analyses of the intra-patient comparison of the HAVEN 3 trial. Curr Med Res Opin. 2019;35(12):2079–2087 [O] . Adriana Reyes, Cédric Révil, Markus Niggli, 2020

机译：回复：Re：Reyes A，Révilc，niggli m等。 eMicizumab预防对因子VIII预防治疗血友病A没有抑制剂的疗效：网络荟萃分析和避风中的患者内部比较的分析。 Curr Med Res opp。 2019; 35（12）：2079-2087
8. Cooperative Study of Spontaneously-Occurring Factor VIII Inhibitors in Patients with Hemophilia A [R] . Shapiro, S. S. 1981

机译：血友病a患者自发性因子VIII抑制剂的合作研究

Rescue factor VIII replacement to secure hemostasis in a patient with hemophilia A and inhibitors on emicizumab prophylaxis undergoing hip replacement

著录项

相似文献

相关主题

期刊订阅